Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of acute otitis media with otorrhea in Italian pediatric practice: a national survey.

Italian journal of pediatrics·2026
Same author

Mixed hearing loss in children: Etiology, management, and audiological outcomes.

International journal of pediatric otorhinolaryngology·2026
Same author

An artificial intelligence classifier as a screening tool to rule out otitis media in children.

International journal of pediatric otorhinolaryngology·2026
Same author

Perceived severity and parental distress after positive expanded newborn screening: parent-clinician concordance and dyadic processes.

European journal of pediatrics·2026
Same author

Catastrophic ENT Complications of Pediatric Infectious Mononucleosis: Recent Experience at a Tertiary Pediatric Hospital.

Journal of clinical medicine·2026
Same author

Long-term otologic and auditory sequelae in children with recurrent acute otitis media.

International journal of pediatric otorhinolaryngology·2026

Related Experiment Video

Updated: May 12, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Panel 7: Treatment and comparative effectiveness research.

Paola Marchisio1, Tasnee Chonmaitree, Eugene Leibovitz

  • 1Department of Pathophysiology and Transplantation, University of Milan and Fondazione IRCCS, Cà Granda Ospedale Maggiore Policlinico, Milan, Italy. paola.marchisio@unimi.it

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|March 29, 2013
PubMed
Summary
This summary is machine-generated.

Antibiotic treatment shows benefits for acute otitis media (AOM) in young children. For otitis media with effusion (OME), adenoidectomy offers no significant advantage over tympanostomy tubes for chronic cases.

Related Experiment Videos

Last Updated: May 12, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Area of Science:

  • Pediatric Otolaryngology
  • Infectious Diseases
  • Evidence-Based Medicine

Background:

  • Otitis media (OM) is a common childhood infection frequently treated with antibiotics.
  • Recent years have seen increased debate and uncertainty surrounding optimal OM treatment strategies.
  • This review addresses current knowledge and future directions in managing various forms of OM.

Purpose of the Study:

  • To review the current state of knowledge on treating acute otitis media (AOM), otitis media with effusion (OME), and chronic suppurative otitis media.
  • To identify and outline promising areas for future research in OM treatment.

Main Methods:

  • A comprehensive literature search was conducted using PubMed, Ovid Medline, Cochrane Database, and Clinical Evidence.
  • Articles published in English between January 2007 and June 2011 focusing on OM treatment were identified.
  • A panel reviewed 286 articles, ultimately selecting 114 high-quality studies for summarization.

Main Results:

  • New evidence supports antibiotic therapy over observation for AOM in young children diagnosed with strict criteria.
  • In chronic OME, adenoidectomy showed no statistically significant benefit compared to tympanostomy tube insertion alone in younger children.
  • Various other treatment modalities for OM were also examined and are discussed.

Conclusions:

  • Substantial advancements have been made in understanding OM treatment.
  • Key areas requiring further investigation have been identified to improve patient outcomes.